行情

SYN

SYN

SYNTHETIC
AMEX
1.150
+0.110
+10.58%
已收盘, 18:09 10/05 EDT
开盘
1.080
昨收
1.040
最高
1.160
最低
1.070
成交量
3.65万
成交额
--
52周最高
4.560
52周最低
0.9700
市值
1,822.07万
市盈率(TTM)
-0.9063
分时
5日
1月
3月
1年
5年
Synthetic Biologics 获得委员会批准在细胞移植受体中推进 SYN-004 试验;股价上涨
Synthetic Biologics 获得委员会批准在细胞移植受体中推进 SYN-004 试验;股价上涨
MT Newswires · 09/27 11:54
SYN 简况
Synthetic Biologics, Inc. is a diversified clinical-stage company. The Company is focused on the development of oncolytic adenovirus platform designed for intravenous and intravitreal delivery to trigger tumor cell death, improve access of co-administered cancer therapies to the tumor, and promote a sustained anti-tumor response by the patient’s immune system. Its lead candidates are: VCN-01, an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade the tumor stroma barrier that serves as a physical and immunosuppressive barrier to cancer treatment; SYN-004 (ribaxamase) which is designed to degrade certain commonly used IV beta-lactam antibiotics within the gastrointestinal (GI) tract, and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under current good manufacturing practice (cGMP) conditions and intended to treat both local GI and systemic diseases.

微牛提供Synthetic Biologics Inc(AMEX-SYN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的SYN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易SYN股票基本功能。